Radioimmunotherapy of malignancy using antibody targeted radionuclides

British Journal of Cancer

Volumn 54, Issue 6, 1986, Pages 863-870

  Cobb, L M ^a   Humm, J L ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RADIOISOTOPE; TUMOR ANTIGEN;

BISMUTH 212; CYTOTOXICITY; DRUG EFFICACY; GENETIC ENGINEERING; HEREDITY; HUMAN; LEAD 209; MERCURY 197; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; THERAPY;

ANIMAL; ANTIBODIES; ANTIGENS, NEOPLASM; BINDING SITES, ANTIBODY; DNA, NEOPLASM; HUMAN; IMMUNOGLOBULIN FRAGMENTS; IODINE RADIOISOTOPES; NEOPLASMS; RADIOISOTOPES;

EID: 0022996868     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1986.254     Document Type: Article

References (66)

1. ALBINO, A.P., LLOYD, O.K., HOUGHTON, A.N., OETTGEN, H.F. & OLD, L.J. (1981). Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. J. Exp. Med., 154, 1764.
2. BADGER, C.C., KROHN, K.A., PETERSON, A.V., SCHULMAN, H. & BERNSTEIN, I.D. (1985). Experimental radiotherapy in murine lymphoma with 131I-labelled anti-Thy 1.1 monoclonal antibody. Cancer Res., 45, 1536.
3. BATEMAN, W.J., VAUGHAN, A.T.M. & BROWN, G. (1983). Selective alpha-irradiation of experimental tumours using astatine-211 labelled monoclonal antibodies. Proc. 7th Int. Cong. Radiat. Res., Amsterdam DI-03. (Abstract).
4. BEGENT, R.H.J., KEEP, P.A., GREEN, A.J. & 6 others (1982). Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody. Lancet, ii, 739.
5. BEGENT, R.H.J., GREEN, A.J., CHESTER, K.A., KEEP, P.A., SEARLE, F. & BAGSHAWE, K.D. (1984). The use of second antibody to improve selective localisation: Clinical studies. Br. J. Cancer, 50, 556. (Abstract).
6. BLÖCHER, D. (1981). Inaugural-dissertation. Strahleninduzierte DNA-Doppelstrangbriiche in Ehrlich Ascites Tumorzellen und ihre mogliche Bedeutung fur das Zelluberleben. Ph.D. Thesis Frankfurt University. Table 6.3, p. 123.
7. BLÖCHER, D. (1982). DNA double strand breaks in Ehrlich ascites tumour cells at low doses of X-rays. I. Determination of induced breaks by centrifugation at reduced speeds. Int. J. Radiat. Biol., 42, 317.
8. BURAGGI, G.L., CALLEGARO, L., MARIANI, G. & 12 others (1985). Imaging with 131I-labelled monoclonal antibodies to a high-molecular-weight melanomaassociated antigen in patients with melanoma: Efficacy of whole immunoglobulin and its F(ab')2 fragments. Cancer Res., 45, 3378.
9. BURCHIEL, S.W., MARTIN, J.C., IMAI, K., FERRONE, S. & WARNER, N.L. (1982). Heterogeneity of HLA-A, B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analysed with monoclonal antibodies and flow cytometry. Cancer Res., 42, 4110.
10. BURKI, H.J., ROOTS, R., FEINENDEGEN, L.E. & BOND, V.P. (1973). Inactivation of mammalian cells after disintegrations of 3H or 1251 in cell DNA at - 196°C. Int. J. Radiat. Biol., 24, 363.
11. CARRASQUILLO, J.A., KROHN, K.A., BEAUMIER, P. & 5 others (1984). Diagnosis of and therapy for solid tumours with radio-labeled antibodies and immune fragments. Cancer Treat. Rep., 68, 317.
12. COBBOLD, S.P. & WALDMANN, H. (1984). Therapeutic potential of monovalent monoclonal antibodies. Nature, 308, 460.
13. COURTENAY-LUCK, N. & 19 others (1984). Antibodyguided irradiation of malignant lesions: Three cases illustrating a new method of treatment. Lancet, i, 1441.
14. DeNARDO, S.J., ERICKSON, K.L., BENJAMAN, E. & 3 others (1982). Monoclonal antibodies for radiation therapy of melanoma. In Nuclear Medicine and Biology, Raynaud, (ed) p. 182. Pergamon Press: Paris.
15. DeNARDO, S.J. , DeNARDO, G.L., PENG, J-S. & COLCHER, D. (1983). Monoclonal antibody radiopharmaceuticals for cancer radioimmunotherapy. In Radioimmunoimaging and Radioimmunotherapy, Burchiel & Rhodes, (eds) p. 405. Elsevier: New York.
16. DIENER, E., DINER, U.E., SINHA, A., XIE, S. & VERGIDIS, R. (1986). Specific immunosuppression by immunotoxins containing daunomycin. Science, 231, 148.
17. DILLMAN, R.O., BEAUREGARD, J.C., SOBOL, R.E. & 4 others (1984). Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. Cancer Res., 44, 2213.
18. EDWARDS, P.A.W. (1985). Heterogenous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. Br. J. Cancer, 51, 149.
19. EDWARDS, P.A.W., SKILTON, R.A., PAYNE, A.W.R. & ORMEROD, M.G. (1985). Antigenic heterogeneity of breast cell lines detected by monoclonal antibodies and its relationship with the cell cycle. J. Cell Sci., 73, 321.
20. EPENETOS, A.A., COURTENAY-LUCK, N., PICKERING, D. & 4 others (1985). Antibody irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br. Med. J., 290, 1463.
21. ETTINGER, D.S., DRAGON, L.H., KLEIN, J., SGAGIAS, M. & ORDER, S.E. (1979). Isotopic immunoglobulin in an integrated multimodal treatment program for a primary liver cancer: A case report. Cancer Treat. Rep., 63, 131.
22. ETTINGER, D.S., ORDER, S.E., WHARAM, M.D. & 3 others (1982). Phase I-II study of isotopic immunoglobulin therapy for primary liver cancer. Cancer Treat. Rep., 66, 289.
23. FARGION, S., CARNEY, D., MULSHINE, J. & 6 others (1986). Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res., 46, 2633.
24. FAWWAZ, R.A., WANG, T.S.T., SRIVASTAVA, S.C. & 4 others (1984). Potential palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy. J. Nucl. Med., 25, 796.
25. FEINENDEGEN, L.E. (1975). Biological damage from the Auger effect: Possible benefits. Radiat. Environ. Biophys., 12, 85.
26. FOSTER, C.S., EDWARDS, P.A.W., DINSDALE, E.A. & NEVILLE, A.M. (1982a). Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Virchows Arch. (Pathol. Anat.), 394, 295.
27. FOSTER, C.S., EDWARDS, P.A.W., DINSDALE, E.A. & NEVILLE, A.M. (1982b). Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch. (Pathol. Anat.), 394, 279.
28. FRANK, M.M., LAWLEY, T.J., HAMBURGER, M.I. & BROWN, E.J. (1983). Immunoglobulin Fc receptorclearance in autoimmune diseases. Ann. Int. Med., 98, 206.
29. GLENNIE, M.J. & STEVENSON, G.T. (1982). Univalent antibodies kill tumour cells in vitro and in vivo. Nature, 295, 712.
30. GOLDENBERG, D.M., GAFFAR, S.A., BENNETT, S.J. & BEACH, J.L. (1981). Experimental radioimmunotherapy of a xenografted human colonic tumour (GW-39) producing CEA. Cancer Res., 41, 4354.
31. GREINER, J.W., HAND, P.H., NOGUCHI, P. & 3 others (1984). Enhanced expression of surface tumorassociated antigens in human breast and colon tumor cells after recombinant human leukocyte a-interferon treatment. Cancer Res., 44, 3208.
32. HAGAN, P.L., HALPERN, S.E. & CHEN, A. (1983). Comparison of In-Ill labelled Fab and whole In-Ill anti-CEA monoclonal antibody (MoAb) in normal mice - human colon tumor models. J. Nucl. Med., 24, P77.
33. HAMBLIN, T.J., ABDUL-AHAD, A.K., GORDON, J., STEVENSON, F.K. & STEVENSON, G.T. (1980). Preliminary experience in treating lymphocytic leukemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br. J. Cancer, 42, 495.
34. HAND, P.H., NUTI, M., COLCHER, D. & SCHLOM, J. (1983). Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumorassociated antigens. Cancer Res., 43, 728.
35. HARRISON, A. & ROYLE, L. (1984). Preparation of a 211At-IgG conjugate which is stable in vivo. Int. J. Appl. Radiat. Isot., 35, 1005.
36. HARRISON, A. & ROYLE, L. (1986). The efflcacy of a 211At-monoclonal antibody in the treatment of a murine T cell lymphoma. Natl Cancer Inst. Mongr. (In press).
37. HIRANO, A. & ZIMMERMAN, H.M. (1972). Fenestrated blood vessels in a metastatic renal carcinoma in the brain. Lab. Invest., 26, 465.
38. HNATOWICH, D.J., VIRZI, F. & DOHERTY, P.W. (1985). DTPA-coupled antibodies labeled with yttrium-90. J. Nucl. Med., 26, 503.
39. HOFER, K.G. (1980). Radiation biology and potential therapeutic applications of radionuclides. Bull. Cancer (Paris), 67, 343.
40. KLEIN, J.L., LING, M.N., LEICHNER, P.K. & 3 others (1985). A model system that predicts effective half-life for radiolabeled antibody therapy. Int. J. Radiat. Oncol. Biol. Phys., 11, 1489.
41. KOZAK, R.W., ATCHER, R.W., GANSOW, O.A. & 3 others (1986). Bismuth-212-labelled anti-Tac monoclonal antibody: a-particle-emitting radionuclides as modalities for radioimmunotherapy. Proc. Natl Acad. Sci., 83, 474.
42. KUFE, D.W., NADLER, L., SARGENT, L. & 5 others (1983). Biological behavior of human breast carcinomaassociated antigens expressed by cellular proliferation. Cancer Res., 43, 851.
43. LARSON, S.M., CARRASQUILLO, J.A., KROHN, K.A. & 8 others (1983). Localisation of 131I-labelled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J. Clin. Invest., 72, 2101.
44. LEICHNER, P.K., KLEIN, J.L., SIEGELMAN, S.S., ETTINGER, D.S. & ORDER, S.E. (1983). Dosimetry of 1311-labelled antiferritin in hepatoma: Specific activities in the tumor and liver. Cancer Treat. Rep., 67, 647.
45. LEICHNER, P.K., KLEIN, J.L., FISHMAN, E.K., SELIGMAN, S.S., ETTINGER, D.S. & ORDER, S.E. (1984). Comparative tumour dose from 131 I-labelled polyclonal anti-ferritin, anti-AFP, anti-CEA in primary liver cancers. Cancer Drug Delivery, 1, 321.
46. LIBER, H.L., LEMOTTE, P.K. & LITTLE, J.B. (1983). Toxicity and mutagenicity of X-rays and 121IdUrd or 3HTdR incorporated in the DNA of human lymphoblast cells. Mutat. Res., 111, 387.
47. LUDATSCHER, R.M., GELLEI, B. & BARZILAI, D. (1979). Ultrastructural observations on the capillaries of human thyroid tumours. J. Pathol., 127, 57.
48. MARTIN, R.F. (1977). Induction of double-stranded breaks in DNA by binding with an 1211-labelled acridine. Int. J. Radiat. Biol., 32, 491.
49. MARTIN, R.F., BRADLEY, T.R. & HODGSON, G.S. (1979). Cytotoxicity of an '251-labelled DNA-binding compound that induces double-strand DNA breaks. Cancer Res., 39, 3244.
50. MEEKER, T.C., LOWDER, J., MALONEY, D.G. & 4 others (1985). A clinical trial of anti-idiotype therapy for B cell malignancy. Blood, 65, 1349.
51. NADLER, L.M., STASHENKO, P., HARDY, R. & 5 others (1980). Serotherapy of a patient with a monoclonal antibody directed against a human lymphomaassociated antigen. Cancer Res., 40, 3147.
52. NATALI, P.G., CAVALIERE, R., BIGOTTI, A. & 5 others (1983). Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. J. Immunol., 130, 1462.
53. ORDER, S.E., KLEIN, J.L., ETTINGER, D. & 3 others (1980a). Use of isotopic immunoglobulin in therapy. Cancer Res., 40, 3001.
54. ORDER, S.E., KLEIN, J.L., ETTINGER, D. & 4 others (1980b). Phase I-II study of radiolabelled antibody integrated in the treatment of primary hepatic malignancies. Int. J. Radiat. Oncol. Biol. Phys., 6, 703.
55. ORDER, S.E., KLEIN, J.L. & LEICHNER, P.K. (1981). Antiferritin IgG antibody for isotopic cancer therapy. Oncol., 38, 154.
56. ORDER, S.E., STILLWAGON, S.B., KLEIN, J.L. & 10 others (1985). Iodine 131 antiferritin, a new treatment modality in hepatoma: A Radiation Therapy Oncology Group study. J. Clin. Oncol., 3, 1573.
57. PECTASIDES, D., STEWART, S., COURTENAY-LUCK, N., & 10 others (1986). Antibody-guided irradiation of malignant pleural and pericardial effusions. Br. J. Cancer, 53, 727.
58. PRIMUS, F.J., BENNETT, S.J., KIM, E.E. & 3 others (1980). Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. Cancer Res., 40, 497.
59. ROSTOCK, R.A., KLEIN, J.L., LEICHNER, P.K. & ORDER, S.E. (1984). Distribution of and physiological factors that affect I3'I-antiferritin tumour localization in experimental hepatoma. Int. J. Radiat. Oncol. Biol. Phys., 10, 1135.
60. SAHAGAN, B.G., DORAI, H., SALTZGABER-MULLER, J. & 9 others (1986). Genetically engineered murine/human chimeric antibody retains specificity for human tumorassociated antigen. J. Immunol. (In press).
61. SIKORA, K., ALDERSON, T., NETHERSELL, A. & SMEDLEY, H. (1985). Tumour localisation by human monoclonal antibodies. Med. Oncol. Tumor Pharmacother., 2, 77.
62. SUTER, L., BROGGEN, J., BROCKER, E.B. & SORG, C. (1985). A tumor-associated antigen expressed in melanoma cells with low malignant potential. Int. J. Cancer, 35, 787.
63. VAUGHAN, A.T.M., BATEMAN, W.J. & FISHER, D.R. (1982). The in vivo fate of a 2 1At labelled monoclonal antibody with known specificity in a murine system. Int. J. Radiat. Oncol. Biol. Phys., 8, 1943.
64. WARENIUS, H.M., GALFRE, G., BLEEHEN, N.M. & MILSTEIN, C. (1981). Attempted targeting of a monoclonal antibody in a human tumour xenograft system. Eur. J. Cancer Clin. Oncol., 17, 1009.
65. WRIGHT, G.L., BECKETT, M.L., STARLING, J.J. & 4 others (1983). Immunohistochemical localisation of prostate carcinoma-associated antigens. Cancer Res., 43, 5509.
66. ZALCBERG, J.R., THOMPSON, C.H., LICHTENSTEIN, M. & McKENZIE, I.F.C. (1984). Tumor immunotherapy in the mouse with the use of 131I-labelled monoclonal antibodies. J. Natl Cancer Inst., 72, 697.